Uroplasty shares soar after winning reimbursement from Medicare
Do you hear that? That's the sound of some mighty back-slapping at Uroplasty Inc.'s (NASDAQ:UPI) headquarters in Minnetonka, Minnesota. After winning Medicare reimbursement Wednesday for its urinary incontinence therapy, the company has seen its stock price jump more than 20 percent to around $5.35 per share.